Wall Street Associates’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$915K Hold
1,500
0.6% 64
2016
Q3
$1.07M Hold
1,500
0.37% 100
2016
Q2
$1.09M Hold
1,500
0.44% 89
2016
Q1
$894K Hold
1,500
0.37% 98
2015
Q4
$858K Hold
1,500
0.24% 148
2015
Q3
$840K Hold
1,500
0.16% 168
2015
Q2
$1.19M Hold
1,500
0.11% 189
2015
Q1
$1.25M Hold
1,500
0.12% 191
2014
Q4
$1.08M Hold
1,500
0.1% 196
2014
Q3
$1.04M Hold
1,500
0.11% 198
2014
Q2
$1.26M Hold
1,500
0.11% 201
2014
Q1
$2.45M Buy
+1,500
New +$2.45M 0.2% 153